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Abstract
Background Electrocardiogram (ECG) assessment plays
a crucial role in patients presenting with chest pain and
suspected acute coronary syndrome (ACS). In a pilot study,
we previously evaluated a capacitive ECG system (cECG)
as a novel ECG technique for a fast and simple ECG
assessment in patients with ST-elevation myocardial
infarction (STEMI). In a next step, the sensitivity and
specificity of this novel ECG technique have to be assessed
in patients with ACS.
Hypothesis The Fast Infarction Diagnosis ECG Trial
(FIDET) is a prospective, bi-center, observer-blinded
noninferiority study to evaluate the cECG compared to the
conventional ECG (kECG) in the clinical practice for ECG
assessment in consecutive patients presenting with sus-
pected ACS.
Methods In 250 patients who were admitted to the hos-
pital, because of an ACS [including STEMI and non-ST-
elevation acute coronary syndrome (NSTE-ACS)], both a
kECG and a cECG recording were performed within a time
lag of less than 10 min.
End points The primary end point will be sensitivity and
specificity of the cECG compared to the kECG in diag-
nosing a STEMI with a margin of noninferiority of 7.5 %.
Secondary end points include sensitivity and specificity of
the cECG compared to the kECG in diagnosing an NSTE-
ACS, safety of the cECG system (adverse event, serious
adverse event and suspected unexpected serious adverse
reaction), parameters of the ECG measurement (PQ-inter-
val, QT-interval, ST-amplitude and heart rate) and mea-
surement duration of the two methods.
Conclusion FIDET is designed as a noninferiority study
to show that a novel cECG system is suitable for the
diagnosis of myocardial infarction in the clinical context
and might even have benefits, for example by offering a
faster and easier ECG assessment.
Keywords Capacitive ECG system  Capacitive
electrodes  Myocardial infarction  Acute coronary
syndrome  Clinical cardiology  ECG assessment
Abbreviations
ACS Acute coronary syndrome
AE Adverse event
cECG Capacitive ECG system
CPU Chest pain unit
eCRF Electronic case report form
ECG Electrocardiogram
ER Emergency room
ICD Implantable cardioverter defibrillator
kECG Conventional (12-lead) ECG
MAL Midaxillary line
MI Myocardial infarction
NSTE-ACS Non-ST-elevation acute coronary syndrome
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SAE Serious adverse event
STEMI ST-elevation myocardial infarction
SUSAR Suspected unexpected serious
adverse reaction
Introduction
In 1902, Willem Einthoven published his first recordings of
the heart from his ‘‘string galvanometer’’ which he named
‘‘elektrocardiogramm’’ [1]. In the past century, the elec-
trocardiogram (ECG) became one of the most frequently
used diagnostic devices all over the world and plays a
crucial role in the diagnosis of acute myocardial infarction
(MI) [2, 3]. This is especially important in the pre-hospital
phase, where an early diagnosis of an ST-elevation myo-
cardial infarction (STEMI) sets the course for the rapid
initiation of reperfusion therapy [4].
A so-called capacitive ECG system (cECG) is a novel
technical innovation, which could be a useful diagnostic
tool for a fast and simple ECG assessment. Unlike the
conventional 12-lead ECG (kECG), there is no need to fix
the electrodes to the skin and no need of electrolyte gel.
This might be very useful in an emergency situation when a
fast diagnosis is especially important, e.g., in patients
presenting with an acute coronary syndrome (ACS). In
hemodynamically unstable patients admitted to the hospital
with shock or pre-shock, the adhesion of the conventional
electrodes to the wet skin sometimes is hardly possible. In
this situation, the application of a cECG system could be
beneficial as well.
In a proof of concept pilot study that was performed
between March 2009 and May 2010, we could show that it
was possible to identify a STEMI with the cECG in clinical
practice [6]. In 66 patients admitted to the hospital, because
of a STEMI a cECG was performed and compared to a
kECG of the same patient. During the course of the study,
the cECG was modified, because the initially used ECG
system was able to detect an anterior MI without a prob-
lem, but did not identify an inferior MI sufficiently. After
adding an additional electrode further away from the
electrodes on the chest at the lower back of the patient, ST-
elevations in the inferior leads II, III and aVF could be
assessed appropriately as well. After these first promising
clinical results, further studies are needed to analyze the




The FIDET study is a prospective, bi-center, observer-
blinded, single-arm noninferiority study, where the partic-
ipant is the control group at the same time (protocol ID
20110819-MO, EUDAMED-No. CIV-11-08-002121). Our
intention is to evaluate the cECG compared to the kECG in
the clinical practice for ECG assessment in consecutive
patients presenting with ACS with regard to reliability and
speed. The trial was funded by Capical GmbH, Braun-
schweig, Germany. It was approved by the ethics com-
mittee of the University Medical Center Go¨ttingen as the
leading ethics committee. As the measurements were car-
ried out in patients who were in a potentially unstable state,
where no time should be wasted, we got permission
to obtain written informed consent after the ECG
assessments.
Conducting patient selection and study
The duration of the study is supposed to be very short.
Consecutive patients presenting to the hospital with ACS
will be screened for inclusion into the study. Taking the
different entities of ACS together (STEMI, NSTE-ACS),
measurements will presumably be conducted in the emer-
gency room (ER), the cardiac catheterization laboratory
(before reperfusion therapy is started) and the chest pain
unit (CPU). Inclusion and exclusion criteria are listed in
Table 1. If a patient fulfills the inclusion and exclusion
criteria, both a cECG and a kECG will be performed with a
time lag of less than 10 min (flowchart of the protocol,
Fig. 1). We choose this short interval to make the different
ECG assessments as comparable as possible. There will be
neither any further examinations nor a follow-up, but some
of the patients’ personal data will be collected in the
electronic case report forms (eCRF) for further analysis.
Table 1 Inclusion and exclusion criteria
Inclusion criteria Exclusion criteria
Male and female patients
C18 years
Pregnant or breastfeeding women
Patients presenting with chest
pain and suspected ACS
(acute coronary syndrome)
Patients carrying a pacemaker
(PM) or implantable
cardioverter defibrillator (ICD)
Signed written informed consent Bundle-branch block visible in
the ECG (except for a new left
bundle-branch block)
A 12-lead ECG is routinely
recorded in the hospital on
admission of the patient
Cardiogenic shock
Patients who recently underwent
an operation at the chest
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We intend to include 250 patients. An interim safety
analysis will be performed after recruitment of the first 100
patients.
Medical device (capacitive ECG system)
and measuring procedure
The used cECG system is shown in Fig. 2; it consists of a
sensor array with 25 flexible mounted capacitive electrodes
integrated into a *20 9 20 cm round mainframe and
another 7 electrodes on the additional probe connected via
cable to the mainframe.
While the measuring principle of the cECG and the
kECG is the same, both detect potential differences during
the electric heart action and the particular sensor (capaci-
tive or galvanic electrode) works in a different mode.
Capacitive electrodes, among other things for ECG mea-
surements, were first described in the 1960s [7–9]. In
contrast to the conventional galvanic electrodes that require
an electrolyte gel for enabling a certain conductivity for
measuring a bioelectric signal, they are isolated from the
body and provide a capacitive coupling between the skin
and a metallic face inside the sensor. The signal is injected
in a capacitive way with high impedance, as the electrode
detects electric displacement currents that are caused by the
changing potential distribution during the heartbeat. For
this purpose, a special amplifier has to be connected to the
metallic face.
With this configuration, it is possible to obtain an ECG
recording with the cECG that gives exactly the same
information as the kECG when the electrodes are placed at
the same position, and comparable results if the capacitive
electrodes are placed in an array like the cECG system used
in this and previous studies [5, 10]. After modification of
the cECG system in the course of our previous pilot study
[6], the current clinical trial will be conducted with model
number 2.0 and the software version 1.0.
For ECG assessment, the system is placed on the
patient’s undressed chest, the mainframe central on the
chest in the range of the third intercostal space and
the additional probe on the left side of the patient in the
range of the fifth intercostal space in the midaxillary line
(MAL) with the upper electrode on the Wilson V6 position
(Fig. 3). The ECG recording is then controlled and saved
by the mainframe, allowing a fast and simple handling.
Once a recording is saved, it is automatically sent to the
laptop via Bluetooth connection, where a further process-
ing of the data is possible.
End points
The FIDET study will include the following end points:
1. Primary end point: sensitivity and specificity of the
cECG in the detection of a STEMI compared to the
international gold standard (kECG)
2. Secondary end points
Fig. 1 Flowchart of the study protocol
Fig. 2 The cECG device used consists of a sensor array with 25
flexible mounted capacitive electrodes integrated into a*20 9 20 cm
round mainframe and another 7 electrodes on the additional probe
connected via cable to the mainframe. The recording is automatically
sent to the laptop via Bluetooth connection
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a. sensitivity and specificity of the cECG in diag-
nosing an NSTEMI compared to the gold standard
(kECG, biomarker)
b. safety of the cECG system; documented by adverse
events (AE), serious adverse events (SAE), occur-
rences, undesirable effects and serious undesirable
effects of the product
c. different parameters of the ECG measurement
(PQ-interval, QT-interval, ST-amplitude and heart
rate)
d. measurement duration of the two different
methods (kECG vs. cECG)
e. diagnostic information of space-resolved ECG
data of all channels of the cECG via temporal
and local analysis in comparison to the kECG as
gold standard
Analysis and statistical considerations
The collected data will be acquired in an electronic CRF.
The study database will be created by using the software
secuTrail. As mentioned above, the FIDET study is
designed as a prospective, bi-center, observer-blinded,
single-arm noninferiority study to prove the suitability of
the cECG for the diagnosis of MI in the clinical context.
The cECG will be compared directly with the 12-lead ECG
as the current gold standard for the diagnosis of MI. For
analysis, evaluation of a 12-lead ECG by an investigator of
one center will be compared to the cECG of the same
patient evaluated by an investigator of the other study site.
As the study is observer blinded, the evaluation of the
cECG will be carried out without knowing the result of the
kECG; therefore, there is no need for a control group.
The sensitivity and specificity of the cECG in detecting a
STEMI compared to the gold standard (kECG) will be
determined using a fourfold table and 95 % confidence
intervals will be calculated. A p value of\0.05 will be con-
sidered as statistically significant. The sensitivity of the cECG
in STEMI detection was estimated to be 92.5 % based on the
data from the prior study. Therefore, 84 patients with STEMI
are needed to stay within the 95 % confidence interval,
choosing a 7.5 % tolerance level. Corresponding results hold
true for specificity. Based on an expected STEMI prevalence
of 35 % in the patient population, a sample size for this study
of approximately 250 patients should be adequate to suffi-
ciently match the requirements for the confidence interval
calculation regarding sensitivity and specificity.
Discussion
One of the most common emergency situations is a patient
presenting with chest pain. Unless proven otherwise, an
ACS is suspected that requires a rapid diagnosis to initiate
further therapy due to the impaired prognosis for patients
with a possible MI. The 12-lead ECG is the most important
diagnostic tool in this setting to distinguish between the
different diseases involving the coronary arteries STEMI,
NSTEMI or unstable angina (the latter two are newly
called NSTE-ACS) [11]. In case of STEMI, a reperfusion
therapy is indicated as soon as possible [4, 12].
Thus, new ECG techniques that offer a faster and easier
ECG assessment are developed [13]. A portable, so-called
cECG system based on capacitive electrodes permits a
measurement of ECG signals without fixing the electrodes
on the patient’s skin or using electrolyte gel. To show that
the cECG is a promising diagnostic tool in the clinical
environment, we performed a pilot study in 66 patients
admitted to the hospital with a STEMI. After modification
of the cECG, we were able to detect both anterior and
inferior MI. To analyze the sensitivity and specificity and
further optimize the cECG system, the FIDET study is
planned as a noninferiority study to prove that the inno-
vative ECG technique is suitable to diagnose MI in the
clinical context. A noninferiority margin of 7.5 % was
Fig. 3 Correct position of the cECG. a Schematic position of the
cECG device on the chest and b demonstration of an ECG assessment
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allowed. Therefore, a kECG as well as a cECG will be
performed in consecutive patients admitted to the hospital
with chest pain, thereby allowing a direct comparison
between the two types of ECG examinations. A total of 250
patients will be included. The primary end point of the
study will be sensitivity and specificity of the cECG
compared to the kECG in diagnosing a STEMI. The pri-
mary end point is defined as sensitivity and specificity for
STEMI diagnosis of the capacitive ECG compared to the
gold standard 12-channel ECG. Per definition, the sensi-
tivity and specificity of the 12-channel ECG is 100 %.
Further, we will analyze the results of the coronary angi-
ography of the STEMI patients to validate the sensitivity of
the 12-channel ECG. This is not possible for specificity,
because not all 250 patients underwent a coronary angi-
ography. In a third step, the 12-channel ECG and the
capacitive ECG will be compared to enzyme elevations.
Basically, the treatment for the individual patient is very
short and simple and a follow-up is not planned.
If the cECG can demonstrate its ability to reliably
diagnose an MI, it might be a quite useful diagnostic device
in hospital and especially in the pre-hospital phase, where a
rapid diagnosis is required [14]. An integration of the cECG
system into the patient monitor used in the emergency
medical service, for example, would make the assessment
of ECG and the subsequent transmission to a PCI center by
the cardiologist on duty very fast, easy and straightforward
and may even further improve outcome [15].
In conclusion, a rapid diagnosis in patients presenting
with chest pain is of utmost importance. The so-called
capacitive ECG system, a novel ECG technique with
capacitive electrodes, was able to identify STEMIs in a
pilot study. The FIDET was designed as a noninferiority
study to investigate sensitivity and specificity of cECG and
thus prove that it is suitable for diagnosing MI in clinical
practice and might even have benefits by offering a par-
ticularly fast and simple ECG assessment.
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